These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 26149113)

  • 21. Simultaneous Time-concentration Analysis of Soman and VX Adducts to Butyrylcholinesterase and Albumin by LC-MS-MS.
    Lee JY; Kim C; Lee YH
    J Anal Toxicol; 2018 Jun; 42(5):293-299. PubMed ID: 29618078
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of Efficiency of Purification (from Human Plasma) of a Nerve Agent Adduct of Butyrylcholinesterase Between the Affinity Gel Method and Immunomagnetic Separation.
    Lee JY
    J Chromatogr Sci; 2018 Mar; 56(3):248-253. PubMed ID: 29244127
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A retrospective screening method for carbamate toxicant exposure based on butyrylcholinesterase adducts in human plasma with ultra-high performance liquid chromatography-tandem mass spectrometry.
    Ren Z; Chen B; Liang D; Liu D; Lei W; Liu S
    J Chromatogr B Analyt Technol Biomed Life Sci; 2023 Jun; 1225():123775. PubMed ID: 37285767
    [TBL] [Abstract][Full Text] [Related]  

  • 24. An enhanced butyrylcholinesterase method to measure organophosphorus nerve agent exposure in humans.
    Pantazides BG; Watson CM; Carter MD; Crow BS; Perez JW; Blake TA; Thomas JD; Johnson RC
    Anal Bioanal Chem; 2014 Aug; 406(21):5187-94. PubMed ID: 24604326
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Studies on the metabolism of the neurotoxic tri-o-cresyl phosphate. Distribution, excretion, and metabolism in male cats after a single, dermal application.
    Nomeir AA; Abou-Donia MB
    Toxicology; 1986 Jan; 38(1):15-33. PubMed ID: 3942008
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Disposition of [14C]tri-o-cresyl phosphate and its metabolites in various tissues of the male cat following a single dermal application.
    Nomeir AA; Abou-Donia MB
    Drug Metab Dispos; 1984; 12(6):705-11. PubMed ID: 6150819
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Profiling cholinesterase adduction: a high-throughput prioritization method for organophosphate exposure samples.
    Carter MD; Crow BS; Pantazides BG; Watson CM; DeCastro BR; Thomas JD; Blake TA; Johnson RC
    J Biomol Screen; 2014 Feb; 19(2):325-30. PubMed ID: 23954929
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mass spectrometry based proteomic approach for the screening of butyrylcholinesterase adduct formation with organophosphates.
    Dubrovskii Y; Murashko E; Chuprina O; Beltyukov P; Radilov A; Solovyev N; Babakov V
    Talanta; 2019 May; 197():374-382. PubMed ID: 30771950
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Studies on the metabolism of the neurotoxic tri-o-cresyl phosphate. Synthesis and identification by infrared, proton nuclear magnetic resonance and mass spectrometry of five of its metabolites.
    Nomeir AA; Abou-Donia MB
    Toxicology; 1986 Jan; 38(1):1-13. PubMed ID: 3942005
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Novel dual-mode immunomagnetic method for studying reactivation of nerve agent-inhibited butyrylcholinesterase.
    Abney CW; Knaack JL; Ali AA; Johnson RC
    Chem Res Toxicol; 2013 May; 26(5):775-82. PubMed ID: 23656164
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Determination of ortho-cresyl phosphate isomers of tricresyl phosphate used in aircraft turbine engine oils by gas chromatography and mass spectrometry.
    De Nola G; Kibby J; Mazurek W
    J Chromatogr A; 2008 Jul; 1200(2):211-6. PubMed ID: 18550071
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Matrix-assisted laser desorption/ionization time-of-flight mass spectrometry of titanium oxide-enriched peptides for detection of aged organophosphorus adducts on human butyrylcholinesterase.
    Jiang W; Murashko EA; Dubrovskii YA; Podolskaya EP; Babakov VN; Mikler J; Nachon F; Masson P; Schopfer LM; Lockridge O
    Anal Biochem; 2013 Aug; 439(2):132-41. PubMed ID: 23624322
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Progress in the development of enzyme-based nerve agent bioscavengers.
    Nachon F; Brazzolotto X; Trovaslet M; Masson P
    Chem Biol Interact; 2013 Dec; 206(3):536-44. PubMed ID: 23811386
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Impairment of glutamate signaling in mouse central nervous system neurons in vitro by tri-ortho-cresyl phosphate at noncytotoxic concentrations.
    Hausherr V; van Thriel C; Krug A; Leist M; Schöbel N
    Toxicol Sci; 2014 Nov; 142(1):274-84. PubMed ID: 25199799
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Characterization of delayed neurotoxicity in the mouse following chronic oral administration of tri-o-cresyl phosphate.
    Lapadula DM; Patton SE; Campbell GA; Abou-Donia MB
    Toxicol Appl Pharmacol; 1985 Jun; 79(1):83-90. PubMed ID: 4049409
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Serum carboxylesterase activity in various strains of rats: sensitivity to inhibition by CBDP (2-/o-cresyl/4H:1:3:2-benzodioxaphosphorin-2-oxide).
    Clement JG; Erhardt N
    Arch Toxicol; 1990; 64(5):414-6. PubMed ID: 2403290
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In vitro neurotoxic hazard characterization of different tricresyl phosphate (TCP) isomers and mixtures.
    Duarte DJ; Rutten JMM; van den Berg M; Westerink RHS
    Neurotoxicology; 2017 Mar; 59():222-230. PubMed ID: 26851706
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacokinetics and metabolism of a single subneurotoxic oral dose of tri-o-cresyl phosphate in hens.
    Suwita E; Abou-Donia MB
    Arch Toxicol; 1990; 64(3):237-41. PubMed ID: 2372235
    [TBL] [Abstract][Full Text] [Related]  

  • 39. High-Confidence Qualitative Identification of Organophosphorus Nerve Agent Adducts to Human Butyrylcholinesterase.
    Mathews TP; Carter MD; Johnson D; Isenberg SL; Graham LA; Thomas JD; Johnson RC
    Anal Chem; 2017 Feb; 89(3):1955-1964. PubMed ID: 28208252
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Small-scale purification of butyrylcholinesterase from human plasma and implementation of a μLC-UV/ESI MS/MS method to detect its organophosphorus adducts.
    John H; Breyer F; Schmidt C; Mizaikoff B; Worek F; Thiermann H
    Drug Test Anal; 2015 Oct; 7(10):947-56. PubMed ID: 25828536
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.